Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INSP Inspire Medical Systems	$126.94 -0.8%	$136.24	$123.00 ▼ $225.00	$3.77B	1.25	559,407 shs	406,188 shs
NARI Inari Medical	$79.97	$79.97	$39.76 ▼ $79.99	$4.68B	1.02	1.47 million shs	N/A
NVRO Nevro	$5.85 +0.1%	$5.85	$3.17 ▼ $10.34	$224.32M	0.81	811,795 shs	753,602 shs
SWAV Shockwave Medical	$334.75	$332.85	$157.00 ▼ $334.90	$12.57B	0.88	968,088 shs	N/A
TNDM Tandem Diabetes Care	$14.77 -3.8%	$19.61	$14.66 ▼ $47.60	$1.02B	1.48	1.50 million shs	1.68 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INSP Inspire Medical Systems	+0.63%	-7.94%	+0.86%	-14.77%	-11.90%
NARI Inari Medical	0.00%	0.00%	0.00%	0.00%	+36.42%
NVRO Nevro	0.00%	0.00%	0.00%	0.00%	-42.00%
SWAV Shockwave Medical	0.00%	0.00%	0.00%	0.00%	0.00%
TNDM Tandem Diabetes Care	-2.48%	-5.01%	-23.47%	-8.90%	-66.34%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INSP Inspire Medical Systems	4.8683 of 5 stars	4.4	2.0	0.0	4.8	2.9	2.5	1.9
NARI Inari Medical	0.2636 of 5 stars	1.1	0.0	0.0	0.0	0.0	2.5	0.6
NVRO Nevro	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SWAV Shockwave Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TNDM Tandem Diabetes Care	4.316 of 5 stars	4.2	1.0	0.0	4.9	4.1	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INSP Inspire Medical Systems	2.73	Moderate Buy	$210.27	65.65% Upside
NARI Inari Medical	2.14	Hold	$69.22	-13.44% Downside
NVRO Nevro	1.92	Reduce	$5.36	-8.29% Downside
SWAV Shockwave Medical	0.00	N/A	N/A	N/A
TNDM Tandem Diabetes Care	2.33	Hold	$32.71	121.49% Upside

Current Analyst Ratings Breakdown

Latest NVRO, SWAV, TNDM, NARI, and INSP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	INSP Inspire Medical Systems	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$200.00 ➝ $182.00
7/9/2025	TNDM Tandem Diabetes Care	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Sell	$24.00 ➝ $14.00
6/16/2025	TNDM Tandem Diabetes Care	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$24.00
5/22/2025	TNDM Tandem Diabetes Care	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$20.00 ➝ $24.00
5/6/2025	INSP Inspire Medical Systems	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$220.00 ➝ $200.00
5/6/2025	INSP Inspire Medical Systems	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$235.00 ➝ $195.00
5/6/2025	INSP Inspire Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$195.00 ➝ $174.00
5/6/2025	INSP Inspire Medical Systems	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$230.00 ➝ $236.00
5/1/2025	TNDM Tandem Diabetes Care	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$58.00 ➝ $59.00
5/1/2025	TNDM Tandem Diabetes Care	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$60.00 ➝ $31.00
5/1/2025	TNDM Tandem Diabetes Care	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$22.00 ➝ $20.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INSP Inspire Medical Systems	$802.80M	4.66	$1.69 per share	74.90	$23.01 per share	5.52
NARI Inari Medical	$493.63M	9.48	$0.09 per share	906.95	$8.07 per share	9.91
NVRO Nevro	$408.52M	0.55	N/A	N/A	$8.10 per share	0.72
SWAV Shockwave Medical	$787.97M	15.95	$4.31 per share	77.61	$20.02 per share	16.72
TNDM Tandem Diabetes Care	$940.20M	1.05	N/A	N/A	$4.01 per share	3.68

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INSP Inspire Medical Systems	$53.51M	$2.17	58.50	39.42	1.96	7.92%	10.00%	8.68%	8/5/2025 (Estimated)
NARI Inari Medical	-$1.64M	-$1.35	N/A	727.00	N/A	-13.68%	-10.09%	-6.60%	N/A
NVRO Nevro	-$92.21M	-$3.05	N/A	N/A	N/A	-16.54%	-23.52%	-10.83%	8/4/2025 (Estimated)
SWAV Shockwave Medical	$147.28M	$4.28	78.21	54.34	2.43	20.75%	24.79%	11.95%	N/A
TNDM Tandem Diabetes Care	-$96.03M	-$2.78	N/A	N/A	N/A	-18.71%	-57.33%	-13.48%	8/6/2025 (Confirmed)

Latest NVRO, SWAV, TNDM, NARI, and INSP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	TNDM Tandem Diabetes Care	-$0.40	N/A	N/A	N/A	$238.39 million	N/A
8/5/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	N/A	N/A	N/A	$214.50 million	N/A
5/5/2025	Q1 2025	INSP Inspire Medical Systems	-$0.23	$0.10	+$0.33	$0.10	$194.89 million	$201.32 million
4/30/2025	Q1 2025	TNDM Tandem Diabetes Care	-$0.60	-$0.67	-$0.07	-$1.97	$220.19 million	$234.42 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
NARI Inari Medical	N/A	N/A	N/A	N/A	N/A
NVRO Nevro	N/A	N/A	N/A	N/A	N/A
SWAV Shockwave Medical	N/A	N/A	N/A	N/A	N/A
TNDM Tandem Diabetes Care	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INSP Inspire Medical Systems	N/A	9.01	7.44
NARI Inari Medical	N/A	1.77	1.40
NVRO Nevro	0.67	5.02	3.76
SWAV Shockwave Medical	0.97	13.81	12.61
TNDM Tandem Diabetes Care	1.99	2.30	1.81

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INSP Inspire Medical Systems	94.91%
NARI Inari Medical	90.98%
NVRO Nevro	95.52%
SWAV Shockwave Medical	95.35%
TNDM Tandem Diabetes Care	N/A

Insider Ownership

Company	Insider Ownership
INSP Inspire Medical Systems	4.10%
NARI Inari Medical	10.60%
NVRO Nevro	3.20%
SWAV Shockwave Medical	3.40%
TNDM Tandem Diabetes Care	1.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INSP Inspire Medical Systems	1,246	29.49 million	28.29 million	Optionable
NARI Inari Medical	800	58.54 million	52.34 million	Optionable
NVRO Nevro	1,090	38.37 million	36.27 million	Optionable
SWAV Shockwave Medical	1,468	37.54 million	36.27 million	Optionable
TNDM Tandem Diabetes Care	2,650	66.61 million	65.34 million	Optionable

NVRO, SWAV, TNDM, NARI, and INSP Headlines

Recent News About These Companies

FY2025 Earnings Estimate for TNDM Issued By Leerink Partnrs

July 18 at 3:01 AM | americanbankingnews.com

Tandem Diabetes Care's SWOT analysis: stock faces headwinds amid market shifts

July 17 at 10:55 PM | investing.com

What is Leerink Partnrs' Estimate for TNDM FY2025 Earnings?

July 16 at 6:46 AM | marketbeat.com

Tandem Diabetes Care (NASDAQ:TNDM) Hits New 52-Week Low - Here's What Happened

July 15 at 2:44 PM | marketbeat.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by Stephens Investment Management Group LLC

July 13, 2025 | marketbeat.com

Earnings Forecast & History for Tandem Diabetes Care Inc (TNDM) | Price ...

July 12, 2025 | investing.com

Citigroup Reaffirms Sell Rating for Tandem Diabetes Care (NASDAQ:TNDM)

July 11, 2025 | americanbankingnews.com

Tandem Diabetes stock falls after Citi downgrades to Sell on competition concerns

July 9, 2025 | au.investing.com

Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes

July 9, 2025 | finance.yahoo.com

Tandem Diabetes Shares Drop Following Citi Downgrade Over Rising Competition

July 9, 2025 | msn.com

Why Tandem Diabetes (TNDM) Shares Are Sliding Today

July 9, 2025 | msn.com

Tandem Diabetes Care (NASDAQ:TNDM) Sets New 12-Month Low - Here's Why

July 9, 2025 | marketbeat.com

Tandem Diabetes Care (NASDAQ:TNDM) Given "Sell" Rating at Citigroup

July 9, 2025 | marketbeat.com

Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 10.0% this week, taking five-year losses to 83%

July 7, 2025 | finance.yahoo.com

Mirae Asset Global Investments Co. Ltd. Sells 265,554 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

July 6, 2025 | marketbeat.com

Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Morningstar

July 2, 2025 | morningstar.comM

RSI Alert: Tandem Diabetes Care (TNDM) Now Oversold

July 2, 2025 | nasdaq.com

TNDM - Tandem Diabetes Care Inc Key Metrics - Morningstar

July 1, 2025 | morningstar.comM

Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025

July 1, 2025 | businesswire.com

Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down - Here's Why

July 1, 2025 | marketbeat.com

TNDM - Tandem Diabetes Care Inc Financials - Morningstar

June 27, 2025 | morningstar.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVRO, SWAV, TNDM, NARI, and INSP Company Descriptions

Inspire Medical Systems NYSE:INSP

$126.94 -1.03 (-0.80%)

Closing price 03:59 PM Eastern

Extended Trading

$127.57 +0.63 (+0.49%)

As of 06:16 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inari Medical NASDAQ:NARI

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Nevro NYSE:NVRO

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Shockwave Medical NASDAQ:SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Tandem Diabetes Care NASDAQ:TNDM

$14.77 -0.59 (-3.84%)

Closing price 04:00 PM Eastern

Extended Trading

$14.78 +0.01 (+0.07%)

As of 07:33 PM Eastern

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time